GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Entia Biosciences ERGO · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Entia Biosciences — daily ERGO Delayed
Market value
$28,137
Last close × shares
Volume
150
Shares, 30 Oct 2026

About Entia Biosciences

Its shares trade under the ticker ERGO. It has been listed since 1 November 2007. In the fiscal year to 31 December 2016, it reported revenue of $265,466 and a net loss of $1.5m. At that date it held total assets of $439,141 and shareholders' equity of −$2.0m.

Entia Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Sherwood, Oregon. The company went IPO on 2007-11-01. The firm also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The firm's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The firm's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

Figures and description from our data supplier, not checked against the company's own report.

More about Entia Biosciences →

Latest on Entia Biosciences

Our reporting

We have not reported on Entia Biosciences yet.

Other Consumer Staples listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Entia Biosciences's ticker?

Entia Biosciences trades as ERGO on its US listing, under ISIN US29384E1047.

What was Entia Biosciences's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.